|
|
735 Pennsylvania Drive
Exton, PA 19341 USA
phone:(484) 713-2100
fax:(484) 713-2900
|
|
| Symbol |
KNSY |
| Exchange |
Nasdaq |
| Founded |
1984 |
| Employees |
333 |
|
|
| www.macropore.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Biomaterials, vascular puncture closure and embolic protection. |
|
| Management |
| Joseph W. Kaufmann, President and CEO; Douglas G. Evans, P.E., Chief Operating Officer; Michael Celano, C.P.A., Chief Financial Officer; Todd M. DeWitt, Vice President of Biomaterials |
| |
|
|
|
|
|
|
| Recent Results |
| For the first quarter of fiscal year 2007, total revenues were $16.3 million, up 28% from the $12.7 million reported in the first quarter of fiscal 2006. |
| |
|
|
|
|
| Keywords |
| cardiovascular, endovascular, thrombus, guidewire, hemodialysis |
|
|
|
| Description |
|
Kensey Nash Corporation is a medical device company known for product development and technology in the fields of resorbable biomaterials and endovascular devices, used in a variety of medical procedures. The Company provides a range of products in multiple medical markets, primarily the endovascular and orthopaedic markets. |
|
| Products / Services |
Kensey Nash's product offerings include the TriActiv System, which provides protection from embolic debris which can become dislodged during saphenous vein graft interventions. The Angio-Seal Vascular Closure Device, which is now manufactured, marketed and sold worldwide by St. Jude Medical, Inc., is a cardiac puncture closure device.
Orthopaedic products include the VITOSS Scaffold FOAM series of products co-developed with Orthovita, Inc. KNC also manufactures several sports medicine products under private labels including meniscal repair tacks, anterior cruciate ligament (ACL) screws, soft tissue attachment screws, and trauma implants.
KNC manufactures for a strategic partner a resorbable growth factor delivery matrix that is commercially available outside the United States. The company has also developed and commercialized products for oral health, wound care and cell research.
|
|
| Technology / Differentiation |
| Collagen is a natural protein and the predominant biomolecule found in blood vessels, dermis, tendons, ligaments, cartilage, and the organic phase of bone. Because of its many appealing characteristics, collagen has a long history of use in medical devices ranging from hemostats and surgical meshes to bone void fillers. The material is ideal because, when purified properly, it is extremely bio-friendly, can be provided in a variety of shapes and sizes, and acts as a temporary scaffold for tissue regeneration. |
|
| Market / Customers |
KNC sells its products via its direct sales organization or through strategic alliances and distributors.
|
|
| Competitors / Substitutes / Alternatives |
Arrow International Inc., Datascope Corp., Vascular Solutions Inc.
|
|
| Status |
| In fiscal 2007, the Company acquired certain assets of the MacroPore Biosurgery spinal and orthopaedic business unit of Cytori Therapeutics, Inc. |
|
|
Additional Information |
| KNC has a European subsidiary in Eschborn, Germany. |
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
